🔎 Trials Near Me

Akèy › Kansè lestomak › Oklahoma › Oklahoma City

Etid klinik pou Kansè lestomak nan Oklahoma City, OK

10 etid pou Kansè lestomak ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • University of Oklahoma Health Sciences Center, Oklahoma City
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Ap rekriteVolontè an sante akeyi
  • Mercy Hospital Oklahoma City, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mercy Hospital Oklahoma City, Oklahoma City
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • University of Oklahoma, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Ap rekriteFaz 1
  • OU Health Stephenson Cancer Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • SSM OKC Hightower Clinical, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT03526835

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • OU Health University of Oklahoma Medical Center, Oklahoma City
  • Stephenson Cancer Center (chemo location), Oklahoma City
  • University of Oklahoma Health Science Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Combination of TATE and PD-1 Inhibitor in Liver Cancer

Ap rekriteFaz 2
  • University of Oklahoma Health Science Center, Oklahoma City
Laj 18 a 80 · Tout sèks · Mizajou Apr 16, 2026 · NCT03259867

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Ap rekriteFaz 1
  • Dren Investigational Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

A Study of NX-1607 in Adults With Advanced Malignancies

Ap rekriteFaz 1
  • University of Oklahoma, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Etid Kansè lestomak nan lòt vil

Lòt etid nan Oklahoma City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.